Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2021-06, Vol.25 (3), p.350-350
Main Authors: Daoud, Ahmed M., Soliman, Karim M., Ali, Hatem K.
Format: Article
Language:English
Subjects:
COVID-19
Humans
Plasmapheresis
SARS-CoV-2
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3
cites cdi_FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3
container_end_page 350
container_issue 3
container_start_page 350
container_title Therapeutic apheresis and dialysis
container_volume 25
creator Daoud, Ahmed M.
Soliman, Karim M.
Ali, Hatem K.
description
doi_str_mv 10.1111/1744-9987.13568
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2427300001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2427300001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EoqUwsyGPLG3t2PkwC6rKRytVaofCarnJRTVK4hC7VN34CfxGfgkuKV255U53z73Dg9A1JQPqa0hjzvtCJPGAsjBKTlD3uDk9zrHooAtr3wgJAs7YOeqwIKYkEryLVgvjoHJaFbjQpXbKaVNZbHJcF8qWql5DA1ZbrCvsGlCu9PT-PJ6_Th--P7-owLV_8lt7hydmi53B5gOa1JSA3RrK-0t0lqvCwtWh99DL0-NyPOnP5s_T8WjWT3nMk36ahYyJfAUsCTPB0kSllOWQxWFIFeOhyAklSRZnKoogIxkRlHmOBlGe8yBKWQ_dtrl1Y943YJ0stU2hKFQFZmNlwIOYEV_Uo8MWTRtjbQO5rBtdqmYnKZF7sXKvTu41yl-x_uPmEL5ZlZAd-T-THghbYKsL2P2XJ5ejRRv8A2pJg1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2427300001</pqid></control><display><type>article</type><title>Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Daoud, Ahmed M. ; Soliman, Karim M. ; Ali, Hatem K.</creator><creatorcontrib>Daoud, Ahmed M. ; Soliman, Karim M. ; Ali, Hatem K.</creatorcontrib><identifier>ISSN: 1744-9979</identifier><identifier>EISSN: 1744-9987</identifier><identifier>DOI: 10.1111/1744-9987.13568</identifier><identifier>PMID: 32710694</identifier><language>eng</language><publisher>Kyoto, Japan: John Wiley &amp; Sons Australia, Ltd</publisher><subject>COVID-19 ; Humans ; Plasmapheresis ; SARS-CoV-2</subject><ispartof>Therapeutic apheresis and dialysis, 2021-06, Vol.25 (3), p.350-350</ispartof><rights>2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3</citedby><cites>FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3</cites><orcidid>0000-0001-6311-3887</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32710694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daoud, Ahmed M.</creatorcontrib><creatorcontrib>Soliman, Karim M.</creatorcontrib><creatorcontrib>Ali, Hatem K.</creatorcontrib><title>Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?</title><title>Therapeutic apheresis and dialysis</title><addtitle>Ther Apher Dial</addtitle><subject>COVID-19</subject><subject>Humans</subject><subject>Plasmapheresis</subject><subject>SARS-CoV-2</subject><issn>1744-9979</issn><issn>1744-9987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAQhi0EoqUwsyGPLG3t2PkwC6rKRytVaofCarnJRTVK4hC7VN34CfxGfgkuKV255U53z73Dg9A1JQPqa0hjzvtCJPGAsjBKTlD3uDk9zrHooAtr3wgJAs7YOeqwIKYkEryLVgvjoHJaFbjQpXbKaVNZbHJcF8qWql5DA1ZbrCvsGlCu9PT-PJ6_Th--P7-owLV_8lt7hydmi53B5gOa1JSA3RrK-0t0lqvCwtWh99DL0-NyPOnP5s_T8WjWT3nMk36ahYyJfAUsCTPB0kSllOWQxWFIFeOhyAklSRZnKoogIxkRlHmOBlGe8yBKWQ_dtrl1Y943YJ0stU2hKFQFZmNlwIOYEV_Uo8MWTRtjbQO5rBtdqmYnKZF7sXKvTu41yl-x_uPmEL5ZlZAd-T-THghbYKsL2P2XJ5ejRRv8A2pJg1Q</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Daoud, Ahmed M.</creator><creator>Soliman, Karim M.</creator><creator>Ali, Hatem K.</creator><general>John Wiley &amp; Sons Australia, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6311-3887</orcidid></search><sort><creationdate>202106</creationdate><title>Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?</title><author>Daoud, Ahmed M. ; Soliman, Karim M. ; Ali, Hatem K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>COVID-19</topic><topic>Humans</topic><topic>Plasmapheresis</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daoud, Ahmed M.</creatorcontrib><creatorcontrib>Soliman, Karim M.</creatorcontrib><creatorcontrib>Ali, Hatem K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic apheresis and dialysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daoud, Ahmed M.</au><au>Soliman, Karim M.</au><au>Ali, Hatem K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?</atitle><jtitle>Therapeutic apheresis and dialysis</jtitle><addtitle>Ther Apher Dial</addtitle><date>2021-06</date><risdate>2021</risdate><volume>25</volume><issue>3</issue><spage>350</spage><epage>350</epage><pages>350-350</pages><issn>1744-9979</issn><eissn>1744-9987</eissn><cop>Kyoto, Japan</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>32710694</pmid><doi>10.1111/1744-9987.13568</doi><tpages>19</tpages><orcidid>https://orcid.org/0000-0001-6311-3887</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1744-9979
ispartof Therapeutic apheresis and dialysis, 2021-06, Vol.25 (3), p.350-350
issn 1744-9979
1744-9987
language eng
recordid cdi_proquest_miscellaneous_2427300001
source Wiley-Blackwell Read & Publish Collection
subjects COVID-19
Humans
Plasmapheresis
SARS-CoV-2
title Potential limitations of plasmapheresis in treatment of COVID‐19 patients: How to overcome them?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A56%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20limitations%20of%20plasmapheresis%20in%20treatment%20of%20COVID%E2%80%9019%20patients:%20How%20to%20overcome%20them?&rft.jtitle=Therapeutic%20apheresis%20and%20dialysis&rft.au=Daoud,%20Ahmed%20M.&rft.date=2021-06&rft.volume=25&rft.issue=3&rft.spage=350&rft.epage=350&rft.pages=350-350&rft.issn=1744-9979&rft.eissn=1744-9987&rft_id=info:doi/10.1111/1744-9987.13568&rft_dat=%3Cproquest_cross%3E2427300001%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4748-cd5339fbe385d93c8ac13fed7551a3459f0108d7da66ed0d0913d93126ff426c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2427300001&rft_id=info:pmid/32710694&rfr_iscdi=true